IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Valeant Pharmaceuticals I

CUSIP: B3XSX46 | 2 institutional holders

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Paradigm Asset Management Co LLC450
0.0% of portfolio›$11.0K
StyleTurnoverLocationFiled
Paradigm Asset Management Co LLC
450$11.0K0.0%GARPHighNew York, NY2016-11-14